The NK1 antagonist aprepitant compared with the 5HT3 antagonist ondansetron for prevention of postoperative nausea and vomiting

被引：0
|
作者：
Candiotti, Keith A. [1 ]
Verma, Usha [1 ]
Diemunsch, Pierre [1 ]
Apfel, Christian [1 ]
Carides, Alexandra [1 ]
Reiss, Theodore [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33152 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2007年 / 109卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：26S / 26S
页数：1
相关论文
共 50 条
  • [31] Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
    Hargreaves, Richard
    Ferreira, Juan Camilo Arjona
    Hughes, David
    Brands, Jos
    Hale, Jeff
    Mattson, Britta
    Mills, Sandy
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010, 2011, 1222 : 40 - 48
  • [32] Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery
    Diemunsch, P
    Schoeffler, P
    Bryssine, B
    Cheli-Muller, LE
    Lees, J
    McQuade, BA
    Spraggs, CF
    BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 (02) : 274 - 276
  • [33] The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting:: Pooled data from 2 randomised, double-blind, placebo controlled trials
    Warr, DG
    Grunberg, SM
    Gralla, RJ
    Hesketh, PJ
    Roila, F
    de Wit, R
    Carides, AD
    Taylor, A
    Evans, JK
    Horgan, KJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1278 - 1285
  • [34] Prevention of chemotherapy induced nausea and vomiting with 5HT3 receptor antagonists and health related QOL
    Garcia Pulgar, M. S.
    Constenla, M.
    Montano, A.
    Garcia Dominguez, R.
    Perez Manga, G.
    Batista, N.
    Ordonez, A.
    Montalar, J.
    Benavides, M.
    Ruiz, M. A.
    Garrido, J.
    Alvarez Sanz, C.
    VALUE IN HEALTH, 2006, 9 (06) : A296 - A296
  • [35] Association of 5-ht3 receptor gene polymorphism with the efficiency of ondansetron for postoperative nausea and vomiting
    Lee, Woo Kyung
    Min, Kyeong Tae
    Shin, Yang-Sik
    Lee, Jeong Rim
    Choi, Seung Ho
    BRITISH JOURNAL OF ANAESTHESIA, 2012, 108 : 376 - 377
  • [36] MCPP BUT NOT TFMPP IS AN ANTAGONIST AT CARDIAC 5HT3 RECEPTORS
    ROBERTSON, DW
    BLOOMQUIST, W
    WONG, DT
    COHEN, ML
    LIFE SCIENCES, 1992, 50 (08) : 599 - 605
  • [37] EFFICACY OF ORAL ONDANSETRON, A SELECTIVE ANTAGONIST OF 5-HT3 RECEPTORS IN THE TREATMENT OF NAUSEA AND VOMITING ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPIES
    CUBEDDU, LX
    PENDERGRASS, K
    RYAN, T
    YORK, M
    BURTON, G
    MESHAD, M
    GALVIN, D
    CIOCIOLA, AA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (02): : 137 - 146
  • [38] Ondansetron, granisetron, and dexamethasone compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
    Erhan, Yamac
    Erhan, Elvan
    Aydede, Hasan
    Yumus, Okan
    Yentur, Alp
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2008, 22 (06): : 1487 - 1492
  • [39] Cost-effectiveness analysis of 5HT3 receptor antagonists for prevention of chemotherapy induced nausea and vomiting
    Ruiz, M. A.
    Garrido, J.
    Garcia, Pulgar M. S.
    Sanz, C.
    VALUE IN HEALTH, 2007, 10 (06) : A329 - A330
  • [40] 5-HT3 ANTAGONISTS IN POSTOPERATIVE NAUSEA AND VOMITING
    RUSSELL, D
    KENNY, GNC
    BRITISH JOURNAL OF ANAESTHESIA, 1992, 69 (07) : S63 - S68
12345